传递爱心策略提升中国男男性行为者淋病与衣原体检测:一项随机对照试验
在中国广州和北京三个MSM社区组织HIV检测点开展随机对照优效试验,301名MSM随机分入传递爱心组、按需付费组和标准护理组。
要点
- 传递爱心策略可显著提高中国MSM淋病和衣原体检测 uptake。
- 传递爱心组中95%参与者愿意捐赠支持他人检测。
核心结论
- 传递爱心策略可提高中国MSM淋病和衣原体检测 uptake,可能有助于扩大需付费的预防服务。
研究设计与样本
- 在中国广州和北京三个MSM社区组织运营的HIV检测点开展随机对照优效试验,纳入301名16岁及以上、寻求HIV检测且符合淋病和衣原体检测指征的MSM。
- 采用限制性随机化,30组按1:1:1随机分入传递爱心组、按需付费组和标准护理组,主要结局为行政记录确认的淋病和衣原体检测 uptake。
主要发现
- 淋病和衣原体检测 uptake 在传递爱心组为56%(57/101),按需付费组为46%(46/100),标准护理组为18%(18/100)。
- 传递爱心组中57人中有54人(95%)选择捐赠以支持他人检测。
临床怎么用
- 在MSM社区HIV检测点可考虑采用传递爱心策略以提升淋病和衣原体检测 uptake。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: WHO recommends that men who have sex with men (MSM) receive gonorrhoea and chlamydia testing, but many evidence-based preventive services are unaffordable. The pay-it-forward strategy offers an individual a gift (eg, a test for sexually transmitted diseases) and then asks whether they would like to give a gift (eg, a future test) to another person. This study examined the effectiveness of a pay-it-forward programme to increase gonorrhoea and chlamydia testing among MSM in China. METHODS: We did a randomised controlled superiority trial at three HIV testing sites run by MSM community-based organisations in Guangzhou and Beijing, China. We included MSM aged 16 years or older who were seeking HIV testing and met indications for gonorrhoea and chlamydia testing. Restricted randomisation was done using computer-generated permuted blocks. 30 groups were randomised into three arms (1:1:1): a pay-it-forward arm in which men were offered free gonorrhoea and chlamydia testing and then asked whether they would like to donate for testing of prospective participants, a pay-what-you-want arm in which men were offered free testing and given the option to pay any desired amount for the test, and a standard-of-care arm in which testing was offered at ¥150 (US$22). There was no masking to arm assignment. The primary outcome was gonorrhoea and chlamydia test uptake ascertained by administrative records. We used generalised estimating equations to estimate intervention effects with one-sided 95% CIs and a prespecified superiority margin of 20%. The trial is registered with ClinicalTrials.gov, NCT03741725. FINDINGS: Between Dec 8, 2018, and Jan 19, 2019, 301 men were recruited and included in the analysis. 101 were randomly assigned to the pay-it-forward group, 100 to the pay-what-you-want group, and 100 to the standard-of-care group. Test uptake for gonorrhoea and chlamydia was 56% (57 of 101 participants) in the pay-it-forward arm, 46% (46 of 100 participants) in the pay-what-you-want arm, and 18% (18 of 100 participants) in the standard-of-care arm. The estimated difference in test uptake between the pay-it-forward and standard-of-care group was 38·4% (95% CI lower bound 28·4%). Among men in the pay-it-forward arm, 54 of 57 (95%) chose to donate to support testing for others. INTERPRETATION: The pay-it-forward strategy can increase gonorrhoea and chlamydia testing uptake among Chinese MSM and could be a useful tool for scaling up preventive services that carry a mandatory fee. FUNDING: US National Institute of Health; Special Programme for Research and Training in Tropical Diseases, sponsored by UNICEF, UNDP, World Bank, and WHO; the National Key Research and Development Program of China; Doris Duke Charitable Foundation; and Social Entrepreneurship to Spur Health.
引用
- Yang F, Zhang TP, Tang W, et al. Pay-it-forward gonorrhoea and chlamydia testing among men who have sex with men in China: a randomised controlled trial. Lancet Infect Dis. 2020. PMID: 32530426. doi:10.1016/S1473-3099(20)30172-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。